Question 1

How big is the Global RNA Therapeutics market?

Accepted Answer

According to Value Market Research, the Global RNA Therapeutics market size was estimated at USD 20.89 Billion in 2025 and is expected to reach USD 22.11 Billion in 2026.

Question 2

What is the Global RNA Therapeutics market growth?

Accepted Answer

The Global RNA Therapeutics market is expected to grow at a CAGR of 5.86% from 2026-2034 to reach USD 34.87 Billion by 2034.

Question 3

Which country holds the highest share in the Global RNA Therapeutics market?

Accepted Answer

North America held the highest share in the Global RNA Therapeutics market.

Question 4

How is the Global RNA Therapeutics market segmented in the report?

Accepted Answer

The Global RNA Therapeutics market is segmented By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, Other Therapeutics), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Other Indications), By End User (Hospitals and Clinics, Research Settings).

Question 5

Who are the key players in the Global RNA Therapeutics market?

Accepted Answer

Some key players include Moderna Inc., Alnylam Pharmaceuticals Inc., Pfizer Inc., Novartis AG and Ionis Pharmaceuticals Inc..

Global RNA Therapeutics Market Size, Share, Trends & Growth Analysis Report Segmented By Product (Vaccines, Drugs), Type, Indication, End User, And Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), 2026-2034